Taking together, it is evident that nimbolide inhibits tumor cell growth and migration by downregulating VEGF-A and MMP-2/9 expression, through the inhibition of ERK1/2, and by reducing nuclear translocations as well as the DNA-binding activities of NF-κB in cancer cells (127). Here, NFKB1 is linked to cancer.